MTR Target

Company Overview

Snapshot

Founded in January 2013 by Zami Yerushalmy and Dr. Iliya Kusner, MTR Target operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on product development and cooperation with medical imaging companies and centers.

Business overview

MTR Target develops medical image-processing CAD applications designed to enhance the efficiency of diagnosis, detection, and classification of lesions. Their core product, the MTR CT Reader, is an automated application that identifies and categorizes lung nodules as malignant, benign, or requiring follow-up. The technology aims to replicate the expertise of practicing radiologists, serving the healthcare industry, particularly hospitals, within the diagnostics and medical devices sectors.

Company Intelligence Q&A

What is MTR Target's primary focus?

MTR Target specializes in developing medical image-processing CAD applications to improve the diagnosis, detection, and classification of lesions.

Who are the founders of MTR Target?

MTR Target was co-founded by Zami Yerushalmy, who serves as CEO, and Dr. Iliya Kusner, the CTO.

What is the MTR CT Reader?

The MTR CT Reader is a fully automatic application developed by MTR Target that detects and classifies lung nodules into 'malignant,' 'benign,' and 'need to follow-up' categories.

What is MTR Target's current product development strategy?

MTR Target is cooperating with companies in the medical imaging field and with medical centers as part of its product development efforts.

Which industries does MTR Target serve?

MTR Target serves the healthcare and life sciences industries, with a focus on providers, particularly hospitals, through its diagnostic devices and software applications.